BackMercury Biopharmaceutical Overview

Mercury Biopharmaceutical Total Assets

Track Mercury Biopharmaceutical's total assets ($260M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$259.89M
↓ 18.02% YoYΔ $-57.13M vs prior year quarter

Peer trimmed avg / median

Loading

Mercury Biopharmaceutical Total Assets History

Loading

Mercury Biopharmaceutical vs. peers: Total Assets Comparison

Loading

Mercury Biopharmaceutical Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mercury Biopharmaceutical (6932.TWO) FAQ

As of the most recent data (June 2026), 6932.TWO shows a total assets of $260M. That compares with $320M in the prior-year period — down 18.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6932.TWO's total assets is now $260M (was $320M) — a 18.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mercury Biopharmaceutical is outperforming or lagging.

Tracking 6932.TWO's total assets over time shows whether Mercury Biopharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $260M That compares with $320M in the prior-year period — down 18.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Mercury Biopharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $260M) with ownership activity and broader fundamentals.